Red light therapy shows genuine promise for tendonitis, but the honest picture is more complicated than the marketing suggests. When used on its own, it performs about the same as other standard treatments for pain relief. Where it gets interesting is when you combine it with exercise: that combination consistently outperforms exercise alone across multiple randomized trials. The catch is that results vary depending on which tendon is affected, what dose you use, and whether you are treating an acute injury or a stubborn chronic problem. The science here is real but uneven, and understanding where the evidence is strong (and where it falls apart) can save you time, money, and frustration.
How Light Affects a Damaged Tendon
When red or near-infrared light (typically between 630 and 1,064 nanometers) hits tissue, it gets absorbed by an enzyme inside your cells’ mitochondria. That absorption kicks off a chain of events that increases energy production in the cells. Lab research on muscle cells has shown that a single session of LED therapy boosts the cell’s energy currency, with peak effects appearing about three to six hours after treatment and staying elevated even at 24 hours.
Tendons heal in three overlapping phases: inflammation, proliferation, and remodeling. A 2022 review found that light therapy acts differently in each phase. During the inflammatory stage, it ramps up production of growth factors that promote new blood vessel formation, which is especially important because many tendons have naturally poor blood supply. During the proliferative phase, light therapy boosts fibroblast activity and increases collagen production. In the remodeling phase, it nudges immune cells toward an anti-inflammatory profile and dials down inflammatory signaling molecules.
A systematic review of preclinical (animal) studies confirmed that photobiomodulation improved the ratio of type I collagen to type III collagen, a key marker of tendon maturity and strength. The pooled effect was substantial, with a standardized mean difference of about 3.0 in favor of treated tendons. That matters because type I collagen is the stronger, more organized form that healthy tendons rely on, while type III collagen is the weaker, patchier version that dominates early in healing.
What the Clinical Trials Actually Show
The largest meta-analysis on red light therapy for tendonitis pooled 17 randomized controlled trials covering 835 patients. Its findings are the most important numbers you need to know, and they tell two very different stories depending on how the therapy was used.
When researchers compared red light therapy head-to-head against other active treatments (like ultrasound, steroid injections, or exercise), the light therapy produced essentially the same amount of pain reduction, with no meaningful difference between the groups. For function, it actually performed slightly worse than comparators. In other words, red light therapy alone is not a magic bullet that outperforms everything else.
But when they looked at trials where light therapy was added on top of an exercise program and compared that to sham light plus the same exercise, the results flipped. The real-light-plus-exercise group had significantly greater pain relief and better functional outcomes than the sham-plus-exercise group. The pain difference was about one full point on a ten-point scale, and functional scores improved meaningfully as well.
That pattern, modest alone but genuinely helpful as an add-on, is the most consistent finding across the research.
Results Differ by Location
Not all tendon problems respond equally to light therapy, and the location of your tendinopathy changes what you can realistically expect.
Shoulder tendons appear to respond particularly well. A study on rotator cuff pathology found that patients receiving photobiomodulation alongside exercise-based rehabilitation saw their pain scores drop from about 7.3 out of 10 down to 2.5 after six weeks. A separate systematic review of high-intensity laser therapy also found that shoulder conditions showed the largest disability improvements compared to other body sites.
For tennis elbow (lateral epicondylitis), the picture is murkier. An umbrella review that pulled together multiple systematic reviews on the topic concluded that the overall evidence for light therapy in managing lateral elbow tendinopathy was poor. Some individual trials showed benefits, but the pooled evidence was not convincing enough to recommend it on its own. A deeper analysis suggested that many of the negative trials used doses or power densities outside the ideal therapeutic window, which may partially explain the inconsistency.
Achilles tendinopathy has received surprisingly little high-quality study. One meta-analysis noted that only a single included trial focused specifically on the Achilles tendon. A more recent three-arm randomized trial in runners with non-insertional Achilles tendinopathy compared exercise alone, exercise plus radial pressure waves, and exercise plus radial pressure waves plus photobiomodulation. All three groups improved, but adding photobiomodulation to the mix did not produce a statistically significant advantage over exercise plus pressure waves alone. The exercise-plus-pressure-waves group actually showed the greatest improvement, gaining 33 points on a validated outcome score compared to 25 points in the group that also got light therapy.
Patellar tendinopathy and other locations have even less dedicated research, making it hard to draw location-specific conclusions for those areas.
Dosing Can Make or Break Treatment
One of the most underappreciated aspects of red light therapy for tendons is that the dose matters enormously, and getting it wrong can actually make things worse. This is not a case where more light equals more healing.
A systematic review of laser therapy for tennis elbow found that the effects were clearly dose-dependent and could be produced by wavelengths across the full red-to-near-infrared spectrum. The anti-inflammatory effect required higher doses than the effect on fibroblast activity and collagen production. But here is the critical finding: when power densities climbed above roughly 100 milliwatts per square centimeter, fibroblast activity and collagen fiber production were actually inhibited rather than stimulated. In other words, too much light can suppress the very healing processes you are trying to encourage.
That same review found that many of the clinical trials reporting negative results for laser therapy had used doses or power densities outside the effective therapeutic window. Some used too much energy. Others treated patients who had a poor prognosis to begin with, such as those with very long symptom durations or prior steroid injections, which can weaken tendon tissue. When the researchers restricted their analysis to trials that used appropriate dosing parameters, the outcomes looked considerably more positive.
This dosing sensitivity is one reason why research findings sometimes conflict so dramatically. Two trials can use the same wavelength and reach opposite conclusions simply because one used twice the power density of the other.
Why Combining It With Exercise Matters
The recurring theme across tendinopathy research is that exercise remains the foundation of treatment. Progressive loading, eccentric exercises, and graded strengthening programs have the strongest evidence base for long-term tendon recovery. Red light therapy does not replace that work. Its value appears to be in making the exercise work better.
The biological rationale is straightforward. Light therapy increases blood flow, reduces inflammation, and primes the cellular machinery for repair. Exercise then provides the mechanical stimulus that guides new collagen fibers to align properly and gain tensile strength. Neither input does both jobs well on its own, but together they cover more of what a damaged tendon needs.
The meta-analysis of 17 trials confirmed this synergy with hard numbers: when light therapy was layered on top of exercise, pain dropped significantly more than with sham light plus exercise. That finding is more robust than any result for light therapy used in isolation. Similarly, the rotator cuff study that reported dramatic pain score drops was specifically combining photobiomodulation with exercise-based rehabilitation, not using light alone.
If you are considering red light therapy for a tendon problem, this is arguably the most practical takeaway. Using it as a standalone treatment is unlikely to outperform what you are already doing. Using it alongside a structured exercise program has a better chance of producing meaningful additional benefit.
High-Intensity Versus Low-Level Therapy
You may see two distinct categories of light therapy discussed in the research: low-level laser therapy (sometimes called LLLT or “cold laser”) and high-intensity laser therapy (HILT). These are not the same thing, and the distinction matters for what you might encounter in a clinic.
Low-level laser therapy uses relatively low power outputs and relies on longer treatment times. Most of the mechanistic research on tendon repair has focused on this type. High-intensity laser therapy delivers substantially more energy in shorter bursts and can penetrate deeper into tissue due to the higher power output.
A systematic review and meta-analysis of high-intensity laser therapy for tendinopathy, covering 15 randomized controlled trials with 629 patients, found significant improvements in both pain and disability. Pain improved by about 1.15 points on a standard scale, and disability scores dropped meaningfully as well. Shoulder conditions benefited more than elbow conditions. An interesting finding was that treatment effects grew over time rather than peaking immediately, with the best outcomes appearing after about 16 weeks. Stress-related pain, the kind you feel during activity rather than at rest, showed the largest reductions.
The practical difference for most people comes down to access. High-intensity laser therapy requires professional-grade equipment and a trained clinician, whereas low-level devices are available for home use. Whether the deeper penetration of high-intensity laser translates to meaningfully better outcomes for superficial tendons remains an open question.
At-Home Devices and What to Expect
The market for consumer red light therapy devices has exploded, and many are marketed for musculoskeletal pain and recovery. Before investing, you should understand what these devices can and cannot do compared to what was used in the clinical research.
Most clinical trials use medical-grade laser diodes with precise wavelength output and known power densities. Consumer LED panels, wraps, and handheld devices often use broader-spectrum LEDs at lower power outputs. Some devices now combine multiple wavelengths: a pilot study testing an LED device designed for home use measured a surface irradiance of about 106 milliwatts per square centimeter, which actually sits right at the upper edge of the range where inhibition of fibroblast activity begins according to the tennis elbow research. The study also documented surface temperature increases between 5.7 and 7.8 degrees Celsius after three minutes of use, with tissue warming extending to depths of 5 millimeters.
Temperature rise matters because part of what people feel during red light therapy may be simple tissue warming, which itself promotes blood flow and can modulate pain perception independently of photobiomodulation. Separating the true photobiological effects from the thermal effects is an ongoing challenge in the research. If your device gets noticeably warm against your skin, some of what you experience may be a heat effect rather than a light-specific one.
Consistency is probably more important than device sophistication. The trials that showed benefit typically used treatments three to five times per week over several weeks. A single session or sporadic use is unlikely to produce meaningful tendon remodeling.
What Animal Research Adds
Animal studies fill some of the gaps that human trials have not yet addressed, particularly around what is actually happening inside the tendon during treatment.
The preclinical meta-analysis of photobiomodulation for tendon regeneration showed that treated tendons had significantly better collagen organization than untreated ones, which is a structural outcome that human trials rarely measure directly. Most human studies rely on patient-reported pain scores and functional questionnaires, so the animal data provides a useful window into whether light therapy changes the tendon itself or just changes how the patient feels about it. The evidence suggests it does both, though the structural effects seen in animal models have been much more consistent than the pain-reduction findings in human trials.
A study on performance horses with tendon and ligament injuries found that high-intensity laser therapy reduced visible lameness and decreased the percentage of the tendon affected by the lesion as measured on ultrasound. However, the echogenicity of the lesion, a measure of how normal the tissue looks on ultrasound, did not change significantly. That is a useful cautionary note: even when light therapy helps symptoms and reduces injury size, it may not fully normalize tissue structure.
Who Should Be Cautious
Red light therapy is generally considered safe with minimal side effects in most research, but a few situations call for caution. People taking photosensitizing medications, including certain antibiotics and some psychiatric drugs, may have exaggerated tissue responses to light. If you have an active infection in or around the tendon, light therapy could theoretically worsen the situation by increasing blood flow to the infected area before the infection is controlled.
Chronic tendinopathy that has been present for many months or years tends to respond less reliably than more recent problems. The tennis elbow research specifically noted that patients with long symptom durations and prior steroid injections had poorer outcomes with light therapy. Steroid injections can degrade tendon collagen over time, potentially leaving less viable tissue for the light therapy to work on. If you have had multiple cortisone shots into a tendon, your mileage with red light therapy may be limited.
Tendons that are partially torn or have calcifications present a different biological situation than tendons that are simply inflamed or degenerating. The research on photobiomodulation has primarily studied tendinopathy, meaning chronic degeneration and overuse, not acute tears. Extrapolating the findings to structural tears is a leap the current evidence does not support.
Why the Research Keeps Contradicting Itself
If you have tried to research this topic before, you have probably noticed that one study says red light therapy works great while the next says it does nothing. This is not because the science is unreliable. It is because the treatment has so many adjustable parameters that small changes in protocol can produce completely different outcomes.
Wavelength, power density, total energy delivered, treatment duration, treatment frequency, the distance between the light source and the skin, whether the treatment is applied before or after exercise, and the specific condition being treated all influence results. A trial using 630 nanometer light at 50 milliwatts per square centimeter for 90 seconds is testing a fundamentally different intervention than one using 830 nanometer light at 200 milliwatts per square centimeter for 60 seconds, even though both are called “red light therapy” or “photobiomodulation.”
The field has recognized this problem and professional organizations have published dosing guidelines, but adherence to those guidelines in published research has been inconsistent. Until more trials converge on standardized protocols, the contradictory findings will persist. If you are choosing a clinic or device, ask specifically about the wavelength, power output, and dose they use, and whether those parameters align with the ranges that have shown benefit in tendon research: roughly 630 to 1,000 nanometers, power densities below 100 milliwatts per square centimeter for low-level therapy, and energy doses consistent with published recommendations.
1PubMed Central. A systematic review with procedural assessments and meta-analysis of Low Level Laser Therapy in lateral elbow tendinopathy (tennis elbow)